TRUALT Share Price | TruAlt Bioenergy Ltd Stock Analysis & Recommendation

Q: Should I buy, sell or hold TruAlt Bioenergy?

Based on the current financial situation of TruAlt Bioenergy, it would be advisable to consider a strong sell position. The company is facing significant challenges, including operating losses and a weak long-term fundamental strength. The high debt level, indicated by a debt-to-equity ratio of 0, further complicates its financial health. Additionally, the negative return on capital employed (ROCE) and the lowest figures for operating profit to interest and net sales suggest that the company is struggling to generate sufficient revenue to cover its costs.While there is an attractive valuation with a ROCE of 8.9 and a positive enterprise value to capital employed ratio, the overall picture is concerning. The stock has not generated any returns over the past year, despite a notable increase in profits. Given these factors, it may be prudent to avoid investing in TruAlt Bioenergy at this time.

Q: Why is TruAlt Bioenergy falling/rising?

As of 18-Jan, TruAlt Bioenergy Ltd's stock price is rising, currently at Rs 370.55, reflecting a change of 5.0 (1.37%) upward. This increase is notable as the stock has outperformed its sector by 1.81% today and reached an intraday high of Rs 375.5, which is a 2.72% increase. However, despite this short-term rise, the stock has shown a negative performance over longer periods, with a decline of 12.17% over the past month and 8.34% year-to-date.The stock is currently trading close to its 52-week low, just 1.77% away from Rs 364. Additionally, it is trading lower than its moving averages across various time frames, indicating a potential weakness in the stock's overall trend. Furthermore, there has been a significant drop in investor participation, with delivery volume falling by 25.68% against the 5-day average, which may suggest a lack of confidence among investors.While the company has attractive valuation metrics, such as a ROCE of 8.9 and a low enterprise value to capital employed ratio, it is also facing significant challenges. The company has reported operating losses and a negative ROCE, alongside a substantial decline in net sales, which fell by 76.3% compared to the previous quarter's average. Additionally, institutional investors have reduced their stake in the company by 0.9%, indicating a potential lack of confidence from more sophisticated investors.In summary, while the stock is experiencing a short-term rise, the underlying fundamentals and declining investor participation suggest ongoing challenges that could impact its future performance.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

53.89 k (-25.27%) Volume

Shareholding (Dec 2025)

FII

0.93%

Held by 14 FIIs

DII

2.34%

Held by 6 DIIs

Promoter

70.55%

Should I buy, sell or hold TruAlt Bioenergy?

18-Dec-2025

Which are the latest news on TruAlt Bioenergy?

18-Jan-2026

TruAlt Bioenergy Stock Falls to 52-Week Low of Rs.364
TruAlt Bioenergy Stock Hits All-Time Low Amidst Continued Decline

Why is TruAlt Bioenergy falling/rising?

19-Jan-2026

As of 18-Jan, TruAlt Bioenergy Ltd's stock price is rising to Rs 370.55, but it has shown negative performance over longer periods, with a decline of 12.17% over the past month. Despite short-term gains, underlying fundamentals and reduced investor participation indicate ongoing challenges for the stock.

View full answer

Compare TruAlt Bioenergy with Similar Stocks

Grauer & Weil Fischer Medical Gujarat Alkalies

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

High Debt Company with a Debt to Equity ratio (avg) at 0 times
The company has reported losses. Due to this company has reported negative ROCE
NET SALES(Q) At Rs 104.48 cr has Fallen at -76.3% (vs previous 4Q average)
OPERATING PROFIT TO INTEREST (Q) Lowest at -0.31 times
PBDIT(Q) Lowest at Rs -11.79 cr.

Falling Participation by Institutional Investors

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Commodity Chemicals

Market cap

INR 3,165 Cr (Small Cap)

P/E

23.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.89

Return on Equity

10.11%

Price to Book

2.29

Revenue and Profits:

Net Sales:

115 Cr

(Quarterly Results - Sep 2025)

Net Profit:

-38 Cr

Total Returns

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-22.53%

6 Months

0.0%

1 Year

0.0%

2 Years

0.0%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

TruAlt Bioenergy for the last several years.

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

TruAlt Bioenergy Stock Falls to 52-Week Low of Rs.364

TruAlt Bioenergy’s shares declined to a fresh 52-week low of Rs.364 on 12 Jan 2026, marking a significant downturn as the stock continues to underperform its sector and broader market indices amid persistent financial headwinds.

Read full news article

TruAlt Bioenergy Stock Hits All-Time Low Amidst Continued Decline

TruAlt Bioenergy’s stock price hit an all-time low of Rs.367.5 today, marking a significant decline amid sustained negative returns and underperformance relative to its sector and the broader market.

Read full news article

TruAlt Bioenergy is Rated Strong Sell

TruAlt Bioenergy is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 January 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Announcements

Appointment of Company Secretary and Compliance Officer

09-Jan-2026 | Source : BSE

Please find attached intimation.

Board Meeting Outcome for Outcome Of Board Meeting

09-Jan-2026 | Source : BSE

Please find attached outcome of Board Meeting held on January 09 2026.

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

08-Jan-2026 | Source : BSE

Please find attached the certificate.

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

EBIT to Interest (avg)

1.28

Debt to EBITDA (avg)

5.14

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

0.64

Tax Ratio

7.58%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

8.20%

ROCE (avg)

8.87%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.29

EV to EBIT

18.96

EV to EBITDA

14.84

EV to Capital Employed

1.68

EV to Sales

2.35

PEG Ratio

Dividend Yield

ROCE (Latest)

8.87%

ROE (Latest)

10.11%

Technicals key factors

Indicator

Weekly

Monthly

No records

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 5 Schemes (4.35%)

FIIs

Held by 14 FIIs (0.93%)

Promoter with highest holding

Vijaykumar Nirani (17.88%)

Highest Public shareholder

Rakeshkumar Viththalbhai Patel (0.038%)

Individual Investors Holdings

14.43%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is -64.45% vs -67.31% in Jun 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is -1,42,600.00% vs -99.97% in Jun 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "104.48",
          "val2": "293.93",
          "chgp": "-64.45%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-11.79",
          "val2": "34.88",
          "chgp": "-133.80%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "38.01",
          "val2": "37.25",
          "chgp": "2.04%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-42.75",
          "val2": "0.03",
          "chgp": "-1,42,600.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-11.28%",
          "val2": "11.87%",
          "chgp": "-23.15%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "398.41",
          "val2": "573.53",
          "chgp": "-30.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "23.10",
          "val2": "27.23",
          "chgp": "-15.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "75.26",
          "val2": "67.15",
          "chgp": "12.08%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-42.72",
          "val2": "-41.99",
          "chgp": "-1.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "5.80%",
          "val2": "4.75%",
          "chgp": "1.05%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,472.80",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "178.14",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "105.61",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "68.24",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "12.10%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,880.12",
          "val2": "1,223.40",
          "chgp": "53.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "297.20",
          "val2": "188.08",
          "chgp": "58.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "141.04",
          "val2": "143.08",
          "chgp": "-1.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "140.62",
          "val2": "31.81",
          "chgp": "342.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "15.81%",
          "val2": "15.37%",
          "chgp": "0.44%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ

Sep'25

Jun'25

Change(%)

Net Sales

104.48

293.93

-64.45%

Operating Profit (PBDIT) excl Other Income

-11.79

34.88

-133.80%

Interest

38.01

37.25

2.04%

Exceptional Items

0.00

Standalone Net Profit

-42.75

0.03

-1,42,600.00%

Operating Profit Margin (Excl OI)

-11.28%

11.87%

-23.15%

Values in Rs Cr.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Sep 2025 is -64.45% vs -67.31% in Jun 2025

Standalone Net Profit

QoQ Growth in quarter ended Sep 2025 is -1,42,600.00% vs -99.97% in Jun 2025

All Quarterly Results

Half Yearly Results Snapshot (Standalone) - Sep'25

Sep'25

Sep'24

Change(%)

Net Sales

398.41

573.53

-30.53%

Operating Profit (PBDIT) excl Other Income

23.10

27.23

-15.17%

Interest

75.26

67.15

12.08%

Exceptional Items

0.00

Standalone Net Profit

-42.72

-41.99

-1.74%

Operating Profit Margin (Excl OI)

5.80%

4.75%

1.05%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Half Yearly Results

Nine Monthly Results Snapshot (Standalone) - Mar'25

Mar'25

Change(%)

Net Sales

1,472.80

Operating Profit (PBDIT) excl Other Income

178.14

Interest

105.61

Exceptional Items

0.00

Standalone Net Profit

68.24

Operating Profit Margin (Excl OI)

12.10%

NA%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Nine Monthly Results

Annual Results Snapshot (Standalone) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

1,880.12

1,223.40

53.68%

Operating Profit (PBDIT) excl Other Income

297.20

188.08

58.02%

Interest

141.04

143.08

-1.43%

Exceptional Items

0.00

Standalone Net Profit

140.62

31.81

342.06%

Operating Profit Margin (Excl OI)

15.81%

15.37%

0.44%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Annual Results

Company CV

About TruAlt Bioenergy Ltd

TruAlt Bioenergy Ltd

Small Cap

Commodity Chemicals

No Details Available.

Company Coordinates

No Company Details Available

TruAlt Bioenergy

1Day

52 Week

CASH

FII

DII

Promoter

Should I buy, sell or hold TruAlt Bioenergy?

Watch in Real-Time

Which are the latest news on TruAlt Bioenergy?

Why is TruAlt Bioenergy falling/rising?

Compare TruAlt Bioenergy with Similar Stocks

MarketsMojo — Loved in India, Now Global

Dashboard

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

Falling Participation by Institutional Investors

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

Returns Beta

News

TruAlt Bioenergy Stock Falls to 52-Week Low of Rs.364

TruAlt Bioenergy Stock Hits All-Time Low Amidst Continued Decline

TruAlt Bioenergy is Rated Strong Sell

Announcements

Appointment of Company Secretary and Compliance Officer

Board Meeting Outcome for Outcome Of Board Meeting

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ

Half Yearly Results Snapshot (Standalone) - Sep'25

Nine Monthly Results Snapshot (Standalone) - Mar'25

Annual Results Snapshot (Standalone) - Mar'25

About TruAlt Bioenergy Ltd

Company Coordinates